73.80
-2.8(-3.66%)
Currency In HKD
Sector
Healthcare
Industry
Biotechnology
Employees
9595
First IPO Date
December 10, 2021
| Name | Title | Pay | Year Born |
| Hao Hong | Founder, Chairman & Chief Executive Officer | 9.89M | 1956 |
| Rui Yang | Co-CEO & Executive Director | 0 | 1977 |
| Da Zhang | Chief Financial Officer, Chief Operating Officer, Senior Vice President & Executive Director | 6.18M | 1981 |
| Liang Hong | Executive VP & Executive Director | 0 | 1974 |
| Pingzhong Huang | Senior Vice President of Business Development & Project Management | 0 | N/A |
| Yan Zhou | Senior Vice President of Quality Management | 0 | 1979 |
| Chaoyong Chen | Executive Vice President of Manufacturing & Tech Transfer | 0 | 1981 |
| Jiang Yingwei | Executive Vice President of Human Resources & Administration | 0 | 1976 |
| Xiangke Xu | Senior Vice President and Board Secretary of Public Affairs & Regulatory Affairs & Legal Affairs | 0 | 1979 |
| Elut Hsu | Senior Vice President of U.S. Headquarters Operations & Business Development | 0 | N/A |
Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.
